Insulet (Nasdaq:PODD) today revealed plans for its innovation pipeline, which includes the next-generation Omnipod 6 system.

The medtech firm plans to launch its next flagship patch-pump in 2027, and its first fully closed loop system for Type 2 ...

Insulet (Nasdaq:PODD) today hosted its Investor Day event, led by CEO Ashley McEvoy, laying out the future for the insulin ...

Insulet Corporation (NASDAQ: PODD) ("Insulet" or the "Company"), the global leader in tubeless insulin pump technology with ...

Shares of Insulet Corporation (PODD) slipped ~7% on Thursday as the insulin pump maker announced its long-term financial ...

Insulet also expects in 2028 to release the Omnipod Fully Closed Loop for Type 2, which will automate insulin delivery for patients with type 2 diabetes. It said the out-of-the-box product will be the ...

Insulet has outperformed the broader market over the past year, and analysts remain strongly bullish on the company’s ...

Diabetes is a chronic health condition affecting blood glucose levels. In some cases, it requires constant management in the form of monitoring blood glucose levels and administering insulin.

Insulin pump-maker Insulet has scored FDA 510(k) clearance for its Omnipod 5 Automated Insulin Delivery System for people ages 6 and up with Type 1 diabetes. The pump integrates with the Dexcom G6 ...

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today presented ...

ACTON, Mass., June 26, 2021--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, ...